We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

51 hedge funds and large institutions have $7.97M invested in Pear Therapeutics, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

13% more funds holding

Funds holding: 45 → 51 (+6)

8% less capital invested

Capital invested by funds: $8.62M → $7.97M (-$647K)

Holders
51
Holders Change
+6
Holders Change %
+13.33%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
4
Closed
3
Calls
$2.78M
Puts
–
Net Calls
+$2.78M
Net Calls Change
+$20K

Top Buyers

Rank Fund Capital Flow
1
BCM
BlueCrest Capital Management
Jersey
+$347K
2
MF
Magnetar Financial
Illinois
+$299K
3
SRF
Silver Rock Financial
California
+$220K
4
AGM
Alpine Global Management
New York
+$174K
5
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$87.4K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$237K
2
PC
Periscope Capital
Ontario, Canada
-$165K
3
WP
Woodline Partners
California
-$70K
4
CAC
Cowen and Company
New York
-$22K
5
Verition Fund Management
Verition Fund Management
Connecticut
-$4.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.82M – – –
LP
2
LMR Partners
United Kingdom
$617K +$12.6K +12,102 +24%
PSAMP
3
P. Schoenfeld Asset Management (PSAM)
New York
$545K +$87.4K +83,846 +17%
AC
4
Aristeia Capital
Connecticut
$366K – – –
KCM
5
Kingstown Capital Management
New York
$366K +$10.4K +10,000 +3%
AGC
6
Angelo Gordon & Co
New York
$331K – – –
BCM
7
BlueCrest Capital Management
Jersey
$317K +$347K +333,333 New
AGM
8
Alpine Global Management
New York
$301K +$174K +166,666 +111%
Citadel Advisors
9
Citadel Advisors
Florida
$262K +$39.2K +37,655 +16%
MF
10
Magnetar Financial
Illinois
$262K +$299K +286,764 New
SC
11
Sculptor Capital
New York
$257K – – –
KC
12
Kepos Capital
New York
$238K – – –
GCL
13
Glazer Capital LLC
New York
$233K -$2.42K -2,323 -0.9%
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$190K – – –
SRF
15
Silver Rock Financial
California
$186K +$220K +211,457 New
CL
16
CSS LLC
Illinois
$163K +$70.4K +67,595 +65%
MCM
17
Moore Capital Management
New York
$158K – – –
TI
18
Telemetry Investments
New York
$119K +$54.3K +52,131 +71%
CCA
19
Castle Creek Arbitrage
Colorado
$107K – – –
Verition Fund Management
20
Verition Fund Management
Connecticut
$106K -$4.67K -4,479 -4%
TCA
21
Taconic Capital Advisors
New York
$95K – – –
UOC
22
UBS O'Connor
Illinois
$76K – – –
DKCM
23
Davidson Kempner Capital Management
New York
$73K – – –
BI
24
Bulldog Investors
New Jersey
$65K -$149 -143 -0.2%
PI
25
PEAK6 Investments
Illinois
$63K – – –
1
2 3

PEARW Hedge Fund Activity: Q3 2021 in Review

51 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q3 2021, worth a combined $7.97M — down 7.5% from $8.62M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PEARW positions and 3 closed out — a net gain of 6 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was BlueCrest Capital Management, opening a new position worth an estimated $347K. The largest seller was Linden Advisors, exiting entirely with an estimated $237K sold.

  • 51 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q3 2021, up from 45 in Q2 2021.
  • Funds reported $7.97M of Pear Therapeutics, Inc. Warrant stock for Q3 2021, down 7.5% quarter-over-quarter.
  • 9 funds opened new Pear Therapeutics, Inc. Warrant positions in Q3 2021 and 3 closed out, a net change of +6 holders.
  • The largest Pear Therapeutics, Inc. Warrant buyer in Q3 2021 was BlueCrest Capital Management, an estimated $347K added.
  • The largest Pear Therapeutics, Inc. Warrant seller in Q3 2021 was Linden Advisors, an estimated $237K sold.

Based on aggregated 13F filings for Q3 2021.